4TEEN4

Developer of procizumab, a monoclonal antibody designed to treat cardiogenic shock

Overview Structured Data Issues Contributors

Is a

Company attributes

Industry

Biopharmaceutical

Medical diagnostics

Biomedical engineering

Location

CEO

Andreas Bergmann

Number of Employees (Ranges)

11 – 50

Email Address

info@4teen4.de

Investors

Wellington Partners

EASME (EU Executive Agency for SMEs)

HBM Healthcare Investments AG

Founded Date

2013

Total Funding Amount (USD)

102,759,000

Latest Funding Round Date

November 13, 2025

CFO

Kilian Jay von Seldeneck

Latest Funding Type

Patents Assigned (Count)

1

COO

Christoph Springer

Country

Headquarters

Other attributes

Latest Funding Round Amount (USD)

64,000,000

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like 4TEEN4

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Golden Query Tool